Active Ingredient: AZELASTINE HYDROCHLORIDE
Proprietary Name: AZELASTINE HYDROCHLORIDE
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 0.05%
Reference Listed Drug: No
Reference Standard: No
TE Code: AT
Application Number: A207411
Product Number: 001
Approval Date: Mar 29, 2019
Applicant Holder Full Name: SOMERSET THERAPEUTICS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information